ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Summit Tells Women To Get A Mammogram, Encourages Others, Too

September 29, 1989

NIH RPG Success Rate to Fall Further

June 7, 2013

Senate Passes Extension Ac; Kennedy Plans Saccharin Hearing

May 13, 1977

Aspirin Use Associated With Lower Cancer Indicence, Death

April 27, 2007

DCT Board Ok’s Grants Program For AIDS Malignancies, Contracts

October 23, 1992

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995